Holding/activity history for Royalty Pharma plc (RPRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 12,094,021 | 1.25 | Add 1.04% | 0.01 | $28.29 |
| 2024 Q2 | 11,970,058 | 1.21 | Add 4.22% | 0.05 | $26.37 |
| 2024 Q1 | 11,485,547 | 1.30 | Add 13.86% | 0.16 | $30.37 |
| 2023 Q4 | 10,087,417 | 1.04 | Add 6.58% | 0.06 | $28.09 |
| 2023 Q3 | 9,464,201 | 1.05 | Reduce 3.93% | 0.04 | $27.14 |
| 2023 Q2 | 9,850,932 | 1.24 | Reduce 12.08% | 0.17 | $30.74 |
| 2023 Q1 | 11,204,249 | 1.90 | Add 11.95% | 0.20 | $36.03 |
| 2022 Q4 | 10,008,511 | 1.99 | Reduce 8.02% | 0.17 | $39.52 |
| 2022 Q3 | 10,881,594 | 2.03 | Reduce 12.04% | 0.28 | $40.18 |
| 2022 Q2 | 12,370,694 | 2.39 | Add 14.92% | 0.31 | $42.04 |
| 2022 Q1 | 10,764,472 | 1.70 | Add 4.35% | 0.07 | $38.96 |
| 2021 Q4 | 10,315,378 | 1.19 | Add 149.13% | 0.71 | $39.85 |
| 2021 Q3 | 4,140,508 | 0.42 | Add 27.85% | 0.09 | $36.14 |
| 2021 Q2 | 3,238,654 | 0.40 | Add 57.08% | 0.15 | $40.99 |
| 2021 Q1 | 2,061,753 | 0.27 | Reduce 9.85% | 0.03 | $43.62 |
| 2020 Q4 | 2,287,000 | 0.31 | Add 17.40% | 0.05 | $50.05 |
| 2020 Q3 | 1,948,064 | 0.30 | Reduce 22.54% | 0.09 | $42.07 |
| 2020 Q2 | 2,514,985 | 0.53 | Buy | 0.53 | $48.55 |